<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>风云药谈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-19T20:40:50+08:00</updated>
  <subtitle>分享、交流、学习</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>重磅来袭：四十亿头孢唑林注射剂首家过评！</title>
    <updated>2021-01-19T20:32:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/0xT_tUqTH0RQvvC4G8aX_g</id>
    <link href="https://mp.weixin.qq.com/s/0xT_tUqTH0RQvvC4G8aX_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采深度分析（限价、产品、格局、）23个产品，收藏！</title>
    <updated>2021-01-16T09:49:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-16:/s/C2eymGBN6eWPUKlrEc7qRg</id>
    <link href="https://mp.weixin.qq.com/s/C2eymGBN6eWPUKlrEc7qRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采现价与报量公布，254亿市场大决战！</title>
    <updated>2021-01-15T17:59:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/8iZJStJxyfrafh0JOC9oRw</id>
    <link href="https://mp.weixin.qq.com/s/8iZJStJxyfrafh0JOC9oRw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采报价在即，原料药企业要翻脸断供！</title>
    <updated>2021-01-14T17:27:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/YGBV3yFhWish1DfH7-uocA</id>
    <link href="https://mp.weixin.qq.com/s/YGBV3yFhWish1DfH7-uocA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采最新格局出炉，春节前能报价落地？</title>
    <updated>2021-01-13T23:04:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/ixNUHF-m1hwcnWLkfo-NPg</id>
    <link href="https://mp.weixin.qq.com/s/ixNUHF-m1hwcnWLkfo-NPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【限量免费】IDC2021化学创新药研发与分析论坛邀请600+大咖于上海共襄盛会</title>
    <updated>2021-01-13T23:04:31+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/lkRdd5jOBa0OZ4rBHxQpAw</id>
    <link href="https://mp.weixin.qq.com/s/lkRdd5jOBa0OZ4rBHxQpAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二批鼓励仿制药物---都是硬货（附白话详解）</title>
    <updated>2021-01-08T17:27:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/Jo7nXitpuTftqvDJK9MqAA</id>
    <link href="https://mp.weixin.qq.com/s/Jo7nXitpuTftqvDJK9MqAA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【精品培训】2021南京站·高端制剂＆改良型新药—专题培训</title>
    <updated>2021-01-08T17:27:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-08:/s/N45Frs6DmCon9V8RJvaZlg</id>
    <link href="https://mp.weixin.qq.com/s/N45Frs6DmCon9V8RJvaZlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20个重点监控产品市场只剩三分之一，非医保的命运“榜样”？</title>
    <updated>2021-01-06T23:42:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-06:/s/PnNd5Imh7aN6MvQkbgxOKw</id>
    <link href="https://mp.weixin.qq.com/s/PnNd5Imh7aN6MvQkbgxOKw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>价格和招采信用评价全面落地，合规面临更大挑战。</title>
    <updated>2021-01-05T17:46:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-05:/s/n2eaZJ5riPIi_6AKyZq38g</id>
    <link href="https://mp.weixin.qq.com/s/n2eaZJ5riPIi_6AKyZq38g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国采新格局，氨溴索11家，帕瑞昔布8家，3进2仅剩19个！</title>
    <updated>2021-01-01T10:43:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-01:/s/zW17KAl3qg21MN1heXwqQA</id>
    <link href="https://mp.weixin.qq.com/s/zW17KAl3qg21MN1heXwqQA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>寄语2021| 不畏过往 奋勇前行  风云药谈祝大家元旦快乐！</title>
    <updated>2020-12-31T23:19:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/yF6vrod6jrBp_PiCGrxX-w</id>
    <link href="https://mp.weixin.qq.com/s/yF6vrod6jrBp_PiCGrxX-w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>